NCT07040904 · RECRUITING

Mindfulness to Enhance Cognitive Health in Latinx Older Adults

This trial is testing whether mindfulness training can support cognitive health in Latinx adults aged 65 and older, with the goal of potentially reducing Alzheimer's risk in this community. Researchers also want to understand the mechanisms behind any benefit they observe. This is a Phase NA behavioral study — it is exploring feasibility and effect, not testing a drug, and nothing is proven or approved.

You may qualify if

  • Hispanic/Latinx
  • Age 65 and older
  • Male, female, or non-binary
  • Community living
  • Medically stable and willing to undergo the study procedures
  • No extensive mindfulness training experience

You're excluded if

  • Clinically unstable psychiatric disorder that requires immediate treatment (e.g., ECT)
  • Medical conditions suggesting significantly shortened lifespan (e.g., metastatic cancer) or prohibiting safe participation in the interventions/assessments (e.g., Parkinson's disease, musculoskeletal conditions)
  • Sensory impairment (hearing, vision) preventing participation
  • Current alcohol or substance abuse
  • Current/concurrent cognitive training known to affect neuroplasticity (e.g., brain-training programs), or other interventions expected to affect neuroplasticity significantly (e.g., psychedelics, cholinesterase inhibitors, high-dose sedatives).

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-06-27

View full record on ClinicalTrials.gov

All APOE4 clinical trials